The −169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case–control study of Koreans

✍ Scribed by Chan-Bum Choi; Changsoo Paul Kang; Sang-Seokg Seong; Sang-Cheol Bae; Changwon Kang

• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 57 KB
• Volume: 54
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.22248

✦ Synopsis

Abstract

Objective

In Japanese individuals, the −169C/T single‐nucleotide polymorphism (SNP) in FCRL3 has been reported to be associated with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and autoimmune thyroid diseases. The objective of this study was to test the association of this SNP with RA and SLE, in a case–control study of Korean individuals.

Methods

The −169C/T SNP in FCRL3 was genotyped in 1,060 patients with RA, 457 patients with SLE, and 697 unaffected control subjects, using the MassARRAY SNP genotyping system. Associations were tested by multivariate logistic regression, with adjustments for age and sex.

Results

No association was detected between the −169C/T SNP and RA (odds ratio [OR] 1.11, 95% confidence interval [95% CI] 0.83–1.48, P = 0.50) or SLE (OR 1.00, 95% CI 0.73–1.37, P = 0.99). This SNP was not associated with rheumatoid factor status, shared epitope status, radiographic severity in patients with RA, or disease manifestations in patients with SLE.

Conclusion

The association of the −169C/T SNP in FCRL3 with RA and SLE that was observed in Japanese patients was not replicated in a Korean population.